To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ITGA3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
364 supporting clones for gene ITGA3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_005501.2   .a 1 to 4884 1 to 4884 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4884/4884
(100 %)
0 diff
(100 %id)
DA774573 brain .a 91 to 647 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
DA339257 hippocampus .a 111 to 637 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA103900 cerebellum .a 136 to 678 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB217200 trachea .a 136 to 703 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA981378 synovial membrane tissue from rheumatioidarthritis .a 140 to 620 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA381336 thalamus .a 207 to 832 2 to 627   capped   626/626
(100 %)
1 diff
(99.9 %id)
CN409341 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 266 to 918 1 to 653       653/653
(100 %)
4 diff
(99.4 %id)
DA311546 hippocampus .a 368 to 933 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
TI_1971556639   .a 393 to 729 344 to 8       337/1269
(26 %)
0 diff
(100 %id)
TI_1971556699   .a 393 to 1152 769 to 11       759/1264
(60 %)
0 diff
(100 %id)
TI_1971557693   .a 393 to 1279 905 to 23       883/966
(91 %)
47 diff
(95.2 %id)
TI_2194644418   .a 393 to 1583 52 to 1228       1177/1295
(90 %)
26 diff
(98.0 %id)
TI_2194645474   .a 393 to 1563 46 to 1216       1171/1285
(91 %)
48 diff
(96.3 %id)
AL547811 placenta, Placenta Cot 25-normalized .a 440 to 1216 1 to 778       778/778
(100 %)
4 diff
(99.5 %id)
TI_1971556697   .a 496 to 1594 1097 to 13   tiling clone,   1085/1251
(86 %)
12 diff
(99.1 %id)
DA376534 thalamus .a 510 to 1068 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
CN409347 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 530 to 1207 1 to 678       678/678
(100 %)
0 diff
(100 %id)
DA417730 thalamus .a 616 to 1182 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BX459614 brain, fetal brain .a 688 to 1576 1 to 887       887/887
(100 %)
8 diff
(99.1 %id)
BX464937 brain, fetal brain .a 688 to 1516 1 to 828       828/828
(100 %)
12 diff
(98.6 %id)
DA853711 placenta .a 761 to 1336 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB278304 uterus .a 867 to 1423 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
TI_1971556633   .a 879 to 2029 1160 to 18       1143/1277
(89 %)
10 diff
(99.3 %id)
BF738889 bladder_tumor .a 939 to 1216 288 to 13     Submitted on the opposite strand 276/288
(95 %)
0 diff
(100 %id)
BE563109 adenocarcinoma, Pancreas .a 999 to 1838 1 to 835       835/954
(87 %)
25 diff
(97.4 %id)
BQ936018 carcinoma, cell line, Prostate .a 1033 to 1924 1 to 896       896/896
(100 %)
8 diff
(99.2 %id)
CN409336 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1035 to 1740 1 to 708       708/708
(100 %)
5 diff
(99.3 %id)
BX369228 Placenta Cot 25-normalized .a 1120 to 1936 1 to 818       818/818
(100 %)
13 diff
(98.5 %id)
BX369229 Placenta Cot 25-normalized .a 1120 to 1933 1 to 815       815/819
(99 %)
11 diff
(98.7 %id)
CN409338 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1123 to 1817 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
BX369230 Placenta Cot 25-normalized .a 1125 to 1792 1 to 672       672/722
(93 %)
20 diff
(97.3 %id)
DA117922 cerebellum .a 1153 to 1712 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB133160 thymus .a 1175 to 1733 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA910162   .a 1177 to 1739 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
CO394020 Chondrosarcoma Lung Metastasis cell lines, lung .a 1186 to 1847 1 to 660       660/852
(77 %)
7 diff
(99.2 %id)
DA687786   .a 1202 to 1744 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CK000899 mixed .a 1237 to 2001 23 to 785       763/809
(94 %)
12 diff
(98.6 %id)
DA658278   .a 1304 to 1864 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
CN409337 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1327 to 1502 1 to 176       176/176
(100 %)
0 diff
(100 %id)
DA656219   .a 1381 to 1956 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB284846 uterus .a 1417 to 1951 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BM043498 carcinoma, cell line, Prostate .a 1433 to 2275 1 to 839       839/844
(99 %)
34 diff
(96.0 %id)
BQ935625 carcinoma, cell line, Prostate .a 1435 to 2322 1 to 895       893/895
(99 %)
23 diff
(97.5 %id)
BU543640 carcinoma, cell line, Prostate .a 1436 to 2290 1 to 858       858/890
(96 %)
7 diff
(99.3 %id)
AL698031 human skeletal muscle .a 1506 to 2118 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
BM552440 astrocytoma grade IV, cell line, brain .a 1566 to 2420 1 to 859   tiling clone,   859/1029
(83 %)
7 diff
(99.4 %id)
CF995834 mixed .a 1566 to 2320 1 to 755       755/755
(100 %)
7 diff
(99.1 %id)
BE272791 Kidney, renal cell adenocarcinoma .a 1604 to 2258 1 to 650       650/682
(95 %)
8 diff
(98.9 %id)
BU526907 epidermoid carcinoma, cell line, lung .a 1620 to 2466 1 to 854       852/856
(99 %)
22 diff
(97.5 %id)
DA581671 lung .a 1624 to 2161 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA856898 placenta .a 1719 to 2298 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA440342 tongue, tumor tissue .a 1723 to 2282 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA724156   .a 1725 to 2254 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
CK000898 mixed .a 1766 to 2542 22 to 796       775/809
(95 %)
16 diff
(98.1 %id)
BI063590 uterus_tumor .a 1806 to 2217 412 to 1       412/412
(100 %)
0 diff
(100 %id)
DA580911   .a 1826 to 2387 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA028658   .a 1835 to 2402 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA183033 amygdala .a 1860 to 2424 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA909550   .a 1867 to 2442 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BE616746 adenocarcinoma, Pancreas .a 1874 to 2725 846 to 8     Submitted on the opposite strand 839/1003
(83 %)
40 diff
(96.1 %id)
BQ355833 head_neck .a 1897 to 2428 538 to 3       534/538
(99 %)
14 diff
(97.4 %id)
BG424727 Kidney, renal cell adenocarcinoma .a 1900 to 2604 1 to 710       710/876
(81 %)
16 diff
(98.2 %id)
BE272530 Kidney, renal cell adenocarcinoma .a 1922 to 2433 1 to 512       512/512
(100 %)
2 diff
(99.7 %id)
DA907832   .a 1936 to 2677 2 to 744   capped   743/743
(100 %)
3 diff
(99.6 %id)
AU140320 placenta .a 1959 to 2853 2 to 889   capped   888/890
(99 %)
21 diff
(97.7 %id)
BG118834 adenocarcinoma, cell line, Liver .a 1962 to 2671 1 to 714       714/1120
(63 %)
15 diff
(98.7 %id)
BG831019 epithelioid carcinoma cell line, Pancreas .a 1973 to 2802 1 to 830       830/832
(99 %)
6 diff
(99.3 %id)
DA954037 Spleen .a 1978 to 2552 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BU165775 melanotic melanoma, skin .a 1979 to 2804 1 to 827       827/893
(92 %)
8 diff
(99.2 %id)
BE907349 epithelioid carcinoma, Pancreas .a 1982 to 2620 1 to 637       637/637
(100 %)
3 diff
(99.6 %id)
CB142419 Liver .a 1993 to 2503 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BQ300060 bladder_tumor .a 2037 to 2440 9 to 415       407/415
(98 %)
19 diff
(95.5 %id)
AW579787 head_neck .a 2046 to 2139 1 to 95       95/102
(93 %)
5 diff
(95.1 %id)
DA032836   .a 2058 to 2637 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AI566132 Kidney .a 2082 to 2609 1 to 528     Submitted on the opposite strand 528/813
(64 %)
8 diff
(99.1 %id)
CA487989   .a 2110 to 2866 1 to 757       757/878
(86 %)
1 diff
(99.9 %id)
CN409343 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2119 to 2653 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BG470216 adenocarcinoma cell line, colon .a 2160 to 2720 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
BM083749 adenocarcinoma cell line, colon .a 2160 to 2819 1 to 662       662/662
(100 %)
5 diff
(99.3 %id)
BG822330 adenocarcinoma cell line, colon .a 2160 to 2865 1 to 716       716/723
(99 %)
30 diff
(95.9 %id)
BG823498 adenocarcinoma cell line, colon .a 2160 to 2866 1 to 710       710/718
(98 %)
12 diff
(98.4 %id)
BI255983 cervical carcinoma cell line, cervix .a 2184 to 2899 1 to 723       723/723
(100 %)
6 diff
(99.2 %id)
DA911560   .a 2195 to 2764 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CA488386   .a 2201 to 3048 1 to 859       859/893
(96 %)
13 diff
(98.6 %id)
BM048615 carcinoma, cell line, Prostate .a 2241 to 2873 1 to 636       636/961
(66 %)
17 diff
(98.3 %id)
BQ900342 carcinoma, cell line, Prostate .a 2246 to 3048 1 to 809       809/904
(89 %)
15 diff
(98.4 %id)
BU152664 carcinoma, cell line, Prostate .a 2246 to 3086 1 to 845       845/850
(99 %)
8 diff
(99.1 %id)
BQ943585 carcinoma, cell line, Prostate .a 2246 to 3157 1 to 916       916/917
(99 %)
12 diff
(98.7 %id)
BQ957424 carcinoma, cell line, Prostate .a 2246 to 3096 1 to 850       850/881
(96 %)
9 diff
(99.0 %id)
DA658236   .a 2258 to 2831 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
CA454888   .a 2295 to 3130 1 to 838   tiling clone,   838/842
(99 %)
9 diff
(99.0 %id)
BU528427 epidermoid carcinoma, cell line, lung .a 2311 to 3208 26 to 928       903/929
(97 %)
13 diff
(98.7 %id)
DB285568 uterus .a 2335 to 2875 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
CA489234   .a 2351 to 2685 1 to 336       336/901
(37 %)
15 diff
(98.4 %id)
DB059184 testis .a 2413 to 2945 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA047978   .a 2422 to 3001 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA654581   .a 2422 to 2972 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA047839   .a 2423 to 2966 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA040947 bladder .a 2429 to 2990 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BE879068 large cell carcinoma, undifferentiated, lung .a 2430 to 3177 1 to 755       752/905
(83 %)
42 diff
(95.4 %id)
BF338811 brain, glioblastoma with EGFR amplification .a 2439 to 3040 1 to 614   AAA   614/1109
(55 %)
28 diff
(97.5 %id)
BE273422 Kidney, renal cell adenocarcinoma .a 2452 to 3176 1 to 716       716/947
(75 %)
18 diff
(98.1 %id)
BE819484 breast_normal .a 2480 to 2682 214 to 16       199/219
(90 %)
1 diff
(99.6 %id)
DA199420 brain .a 2485 to 3070 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
BE875066 large cell carcinoma, undifferentiated, lung .a 2488 to 3168 1 to 675       675/886
(76 %)
31 diff
(96.6 %id)
DA583468 lung .a 2568 to 3118 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BU502495 carcinoma, cell line, Prostate .a 2569 to 3370 35 to 842       808/979
(82 %)
14 diff
(98.6 %id)
BU541644 carcinoma, cell line, Prostate .a 2569 to 3385 27 to 852       826/965
(85 %)
21 diff
(97.9 %id)
BG423242 Kidney, renal cell adenocarcinoma .a 2591 to 3376 1 to 787       785/789
(99 %)
22 diff
(97.3 %id)
BQ641477 eye, normal pigmented retinal epithelium .a 2634 to 3385 21 to 771       751/1005
(74 %)
13 diff
(98.8 %id)
CA488877   .a 2634 to 3343 1 to 706       706/819
(86 %)
11 diff
(98.7 %id)
CX871032 embryonic stem .a 2665 to 3425 1 to 761       761/761
(100 %)
0 diff
(100 %id)
CB150198 Liver .a 2667 to 2808 1 to 142       142/142
(100 %)
0 diff
(100 %id)
DA750334   .a 2673 to 3253 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BG421596 Kidney, renal cell adenocarcinoma .a 2682 to 3329 1 to 645       645/645
(100 %)
6 diff
(99.1 %id)
DA576173   .a 2699 to 3262 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BG739842 skin .a 2717 to 3452 1 to 734       734/736
(99 %)
3 diff
(99.6 %id)
BG425039 Kidney, renal cell adenocarcinoma .a 2737 to 3510 1 to 766   tiling clone,   766/929
(82 %)
26 diff
(97.3 %id)
BQ217748 epithelioid carcinoma, Pancreas .a 2740 to 3510 1 to 781       781/954
(81 %)
32 diff
(96.7 %id)
DA046772   .a 2757 to 3508 2 to 756   tiling clone, capped   755/789
(95 %)
7 diff
(99.2 %id)
BU542348 carcinoma, cell line, Prostate .a 2773 to 3385 167 to 781       615/1402
(43 %)
9 diff
(99.4 %id)
BM043914 carcinoma, cell line, Prostate .a 2774 to 3490 1 to 729       729/788
(92 %)
20 diff
(97.5 %id)
BM047012 carcinoma, cell line, Prostate .a 2774 to 3507 1 to 735   tiling clone,   735/761
(96 %)
6 diff
(99.3 %id)
BM763881 myeloma .a 2788 to 3402 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
DA008577 adipose .a 2814 to 3305 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
CF619265 Pooled Chondrosarcoma Tumor cells .a 2835 to 3434 9 to 609       601/916
(65 %)
9 diff
(99.1 %id)
DA373045 thalamus .a 2855 to 3467 2 to 614   tiling clone, capped   613/613
(100 %)
0 diff
(100 %id)
TI_59387268   .a 2876 to 3470 60 to 658       599/690
(86 %)
8 diff
(98.9 %id)
DA909482   .a 2913 to 3480 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CD614202   .a 3218 to 3398 1 to 181       181/181
(100 %)
0 diff
(100 %id)
CX865194 embryonic stem .a 3502 to 4327 8 to 833       826/833
(99 %)
6 diff
(99.3 %id)
TI_1971556627   .a 3509 to 4223 727 to 12       716/1230
(58 %)
0 diff
(100 %id)
TI_59387859   .a 3509 to 4224 120 to 852   tiling clone,   733/757
(96 %)
28 diff
(96.4 %id)
BF340165 brain, glioblastoma with EGFR amplification .a 3510 to 4169 1 to 656       656/657
(99 %)
6 diff
(99.1 %id)
CB143053 Liver .a 3517 to 4025 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BI193167 epithelioid carcinoma cell line, Pancreas .a 3548 to 4204 1 to 657       657/657
(100 %)
3 diff
(99.6 %id)
BE733747 choriocarcinoma, placenta .a 3555 to 4302 1 to 752       752/776
(96 %)
38 diff
(95.2 %id)
BQ222520 epithelioid carcinoma, Pancreas .a 3574 to 4487 1 to 923       923/963
(95 %)
17 diff
(98.3 %id)
BM556250 amelanotic melanoma, cell line, skin .a 3630 to 4425 1 to 808       808/1163
(69 %)
29 diff
(97.6 %id)
CN409335 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3638 to 4075 1 to 438       438/438
(100 %)
0 diff
(100 %id)
CB141168 Liver .a 3658 to 4170 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BX391688 Placenta Cot 25-normalized .a 3666 to 4133 469 to 1       469/473
(99 %)
2 diff
(99.6 %id)
TI_2194644421   .a 3677 to 4368 762 to 71       692/762
(90 %)
0 diff
(100 %id)
TI_2194645856   .a 3679 to 4368 761 to 71       691/1290
(53 %)
0 diff
(100 %id)
DA664304   .a 3683 to 4457 2 to 775   capped   774/776
(99 %)
7 diff
(99.1 %id)
BG179713 adenocarcinoma, cell line, Prostate .a 3687 to 4439 1 to 747       747/934
(79 %)
8 diff
(99.2 %id)
BG775103 carcinoma, cell line, Prostate .a 3693 to 4258 1 to 564   fully sequenced,   564/564
(100 %)
2 diff
(99.7 %id)
BM045725 carcinoma, cell line, Prostate .a 3693 to 4481 1 to 790       790/874
(90 %)
7 diff
(99.2 %id)
BM046478 carcinoma, cell line, Prostate .a 3694 to 4456 1 to 759       759/760
(99 %)
10 diff
(98.7 %id)
TI_57230398   .a 3712 to 4510 85 to 883       799/800
(99 %)
14 diff
(98.3 %id)
BI871182 adenocarcinoma, cell line, Liver .a 3713 to 4510 1 to 798       798/799
(99 %)
14 diff
(98.3 %id)
CB126605 Liver .a 3720 to 4298 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BG680667 skin, squamous cell carcinoma .a 3734 to 3891 1 to 158       158/158
(100 %)
0 diff
(100 %id)
BG748002 eye, normal pigmented retinal epithelium .a 3740 to 4656 1 to 917       917/928
(98 %)
40 diff
(95.7 %id)
BG163574 hypernephroma, cell line, Kidney .a 3744 to 4509 1 to 764       764/802
(95 %)
28 diff
(96.6 %id)
BQ717031 sympathetic trunk .a 3750 to 4630 1 to 890       890/906
(98 %)
26 diff
(97.2 %id)
BU542706 carcinoma, cell line, Prostate .a 3758 to 4610 1 to 864       864/873
(98 %)
21 diff
(97.6 %id)
BG678389 skin, squamous cell carcinoma .a 3759 to 3891 1 to 133       133/133
(100 %)
0 diff
(100 %id)
BE746366 adenocarcinoma cell line, ovary .a 3768 to 4353 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
BE798306 lung, small cell carcinoma .a 3790 to 4644 1 to 842   tiling clone,   842/994
(84 %)
20 diff
(98.0 %id)
BM046090 carcinoma, cell line, Prostate .a 3793 to 4567 1 to 778       778/778
(100 %)
19 diff
(97.6 %id)
BG741508 skin .a 3801 to 3891 1 to 91       91/91
(100 %)
0 diff
(100 %id)
BG423463 Kidney, renal cell adenocarcinoma .a 3802 to 4556 1 to 749       749/953
(78 %)
22 diff
(97.7 %id)
BQ931007 carcinoma, cell line, Prostate .a 3806 to 4495 34 to 726   AAA   693/1023
(67 %)
31 diff
(97.0 %id)
BG676112 skin, squamous cell carcinoma .a 3837 to 4597 1 to 759       759/760
(99 %)
4 diff
(99.5 %id)
BG326477 Kidney, renal cell adenocarcinoma .a 3842 to 4732 1 to 882       882/976
(90 %)
45 diff
(95.4 %id)
CX865175 embryonic stem .a 3867 to 4237 1 to 371     Submitted on the opposite strand 371/371
(100 %)
7 diff
(98.2 %id)
BX445955 brain, fetal brain .a 3891 to 4839 945 to 1       945/955
(98 %)
23 diff
(97.6 %id)
BX459613 brain, fetal brain .a 3921 to 4825 925 to 28       898/925
(97 %)
0 diff
(100 %id)
TI_149301359   .a 3961 to 4879 967 to 59       909/1020
(89 %)
0 diff
(100 %id)
BI769682 pooled lung and spleen .a 3996 to 4749 1 to 755       755/755
(100 %)
7 diff
(99.1 %id)
TI_57179846   .a 3996 to 4749 32 to 786       755/786
(96 %)
6 diff
(99.3 %id)
AL572622 placenta, Placenta Cot 25-normalized .a 4002 to 4847 847 to 1       847/847
(100 %)
1 diff
(99.9 %id)
TI_154124603   .a 4021 to 4880 951 to 104   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 848/963
(88 %)
29 diff
(97.0 %id)
TI_227714491   .a 4029 to 4884 946 to 93   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 854/1010
(84 %)
9 diff
(99.2 %id)
TI_159714481   .a 4095 to 4880 864 to 85   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 780/987
(79 %)
24 diff
(97.6 %id)
TI_154127022   .a 4098 to 4880 871 to 101   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 771/907
(85 %)
28 diff
(97.0 %id)
CA311235 Human Lung Epithelial cells, lung .a 4104 to 4884 797 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 779/779
(100 %)
6 diff
(99.3 %id)
TI_149312650   .a 4108 to 4884 862 to 88   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 775/940
(82 %)
4 diff
(99.6 %id)
CD365084 Alveolar Macrophage, lung .a 4121 to 4884 781 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 763/767
(99 %)
8 diff
(99.0 %id)
BG830026 epithelioid carcinoma cell line, Pancreas .a 4128 to 4886 1 to 761       761/786
(96 %)
13 diff
(98.4 %id)
CX754116 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4130 to 4872 1 to 735     Submitted on the opposite strand 735/746
(98 %)
13 diff
(98.3 %id)
CX762808 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4130 to 4786 1 to 649     Submitted on the opposite strand 649/720
(90 %)
20 diff
(97.3 %id)
TI_154126627   .a 4136 to 4879 830 to 92       739/1023
(72 %)
0 diff
(100 %id)
CA443825 Fibrosarcoma .a 4146 to 4879 752 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 734/734
(100 %)
3 diff
(99.6 %id)
BU629555 cell lines, Chondrosarcoma .a 4149 to 4880 751 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 733/734
(99 %)
3 diff
(99.6 %id)
BQ000505 Fibrosarcoma .a 4150 to 4880 747 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 729/729
(100 %)
6 diff
(99.2 %id)
BU685076 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4158 to 4879 743 to 21       723/743
(97 %)
0 diff
(100 %id)
BM978115 lung .a 4166 to 4884 738 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 720/720
(100 %)
1 diff
(99.9 %id)
BU631476 cell lines, Chondrosarcoma .a 4169 to 4884 732 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
CA443506 lung, Metastatic Chondrosarcoma .a 4170 to 4880 727 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 709/712
(99 %)
5 diff
(99.3 %id)
AI921508 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4175 to 4880 708 to 1       708/711
(99 %)
22 diff
(97.0 %id)
AI832602 colon .a 4177 to 4880 704 to 1       704/704
(100 %)
17 diff
(97.6 %id)
BF378866 uterus .a 4180 to 4754 572 to 1       572/574
(99 %)
4 diff
(99.4 %id)
BQ772485 Chondrosarcoma Cell line .a 4201 to 4884 702 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 685/685
(100 %)
3 diff
(99.6 %id)
CA416714 Chondrosarcoma Cell line .a 4202 to 4879 698 to 21       678/698
(97 %)
0 diff
(100 %id)
BU616326 Bone, Subchondral Bone .a 4205 to 4879 693 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 675/677
(99 %)
1 diff
(99.9 %id)
CA438228 lung, Metastatic Chondrosarcoma .a 4205 to 4884 699 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 681/682
(99 %)
3 diff
(99.6 %id)
BQ775856 Bone, Human Chondrosarcoma Cell Line .a 4205 to 4873 694 to 26   AAA   669/678
(98 %)
0 diff
(100 %id)
BU629183 cell lines, Chondrosarcoma .a 4205 to 4880 696 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 678/680
(99 %)
3 diff
(99.6 %id)
BQ772862 Chondrosarcoma Cell line .a 4207 to 4880 693 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 675/675
(100 %)
3 diff
(99.6 %id)
BQ887550 carcinoma, cell line, Prostate .a 4208 to 4880 1 to 673   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 673/673
(100 %)
1 diff
(99.9 %id)
BQ774843 Bone, Human Chondrosarcoma Cell Line .a 4209 to 4880 693 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 675/675
(100 %)
5 diff
(99.3 %id)
BG775700 carcinoma, cell line, Prostate .a 4228 to 4832 603 to 1   fully sequenced,   603/603
(100 %)
5 diff
(99.2 %id)
BU630624 cell lines, Chondrosarcoma .a 4229 to 4884 674 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 656/656
(100 %)
2 diff
(99.7 %id)
AA150649 uterus .a 4235 to 4478 1 to 243   fully sequenced,   243/243
(100 %)
1 diff
(99.6 %id)
AA143174 uterus .a 4235 to 4550 1 to 321   fully sequenced,   321/321
(100 %)
2 diff
(99.4 %id)
BM700122 eye, lens .a 4247 to 4759 1 to 513       513/513
(100 %)
3 diff
(99.5 %id)
BQ684657 melanotic melanoma, cell line, skin .a 4253 to 4881 1 to 629       629/668
(94 %)
3 diff
(99.6 %id)
BQ682208 melanotic melanoma, cell line, skin .a 4253 to 4887 1 to 636       636/666
(95 %)
5 diff
(99.3 %id)
BE741112 adenocarcinoma cell line, ovary .a 4274 to 4884 1 to 611   tiling clone,   611/611
(100 %)
1 diff
(99.9 %id)
TI_154124703   .a 4309 to 4881 741 to 166   AAA   576/1035
(55 %)
0 diff
(100 %id)
BU627888 Bone, Enchondroma cell line .a 4326 to 4884 578 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 560/560
(100 %)
4 diff
(99.3 %id)
DB331329   .a 4349 to 4880 531 to 1       531/531
(100 %)
18 diff
(96.7 %id)
TI_149305372   .a 4365 to 4880 604 to 88   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 517/977
(52 %)
3 diff
(99.7 %id)
BM710512 eye, RPE and Choroid .a 4365 to 4875 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
BM716378 eye, RPE and Choroid .a 4365 to 4758 1 to 394       394/394
(100 %)
1 diff
(99.8 %id)
BE179213 head_neck .a 4377 to 4658 313 to 20     Submitted on the opposite strand 294/313
(93 %)
41 diff
(87.0 %id)
TI_151746779   .a 4378 to 4880 619 to 112       508/1195
(42 %)
0 diff
(100 %id)
AI493178 uterus .a 4411 to 4880 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AW804595 uterus .a 4428 to 4762 14 to 348       335/358
(93 %)
2 diff
(99.5 %id)
AA142946 uterus .a 4448 to 4884 433 to 1   fully sequenced,   433/433
(100 %)
5 diff
(98.9 %id)
AU158423 placenta .a 4470 to 4884 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
AA142897 uterus .a 4520 to 4884 369 to 1   fully sequenced,   369/369
(100 %)
7 diff
(98.2 %id)
T29886 thyroid gland .a 4553 to 4880 1 to 328       328/328
(100 %)
0 diff
(100 %id)
AW338639 adenocarcinoma, Pancreas .a 4577 to 4880 304 to 1       304/304
(100 %)
0 diff
(100 %id)
CB306966 Human Lung Epithelial cells, lung .a 4581 to 4880 318 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 300/300
(100 %)
0 diff
(100 %id)
CA415758 Chondrosarcoma Cell line .a 4583 to 4880 316 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 298/298
(100 %)
0 diff
(100 %id)
NM_002204.2   .b 1 to 5026 1 to 5026 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 5026/5026
(100 %)
0 diff
(100 %id)
BC150190 Donated clones,Novartis FGA collection .b 150 to 5021 1 to 4872 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4872/4872
(100 %)
1 diff
(100.0 %id)
AK289961 hippocampus .b 367 to 3969 1 to 3603 exact     3603/3603
(100 %)
1 diff
(100.0 %id)
M59911   .b 392 to 5022 1 to 4637 exact tiling clone,   4637/4637
(100 %)
25 diff
(99.5 %id)
BC136636 Testicle, PCR rescued clones .b 393 to 4510 1 to 4118 exact tiling clone,   4118/4118
(100 %)
1 diff
(100.0 %id)
BC144328 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .b 393 to 4510 1 to 4118 L529F     4118/4118
(100 %)
2 diff
(100.0 %id)
D01038 bladder carcinoma .b 561 to 3620 1 to 3060       3060/3060
(100 %)
0 diff
(100 %id)
TI_1971557681   .b 2391 to 3573 1188 to 14       1175/1315
(89 %)
13 diff
(99.1 %id)
TI_1971556673   .b 2602 to 3674 1072 to 5       1068/1271
(84 %)
7 diff
(99.5 %id)
BM020041 astrocytoma grade IV, cell line, brain .b 2752 to 3578 1 to 824       824/824
(100 %)
12 diff
(98.6 %id)
TI_59390819   .b 2753 to 3578 107 to 929       823/823
(100 %)
11 diff
(98.7 %id)
CA489607   .b 2829 to 3698 1 to 882       878/921
(95 %)
23 diff
(97.6 %id)
BQ939889 epidermoid carcinoma, cell line, lung .b 2835 to 3651 35 to 859       825/994
(82 %)
36 diff
(96.4 %id)
BQ073731 epidermoid carcinoma, cell line, lung .b 2836 to 3702 1 to 871       869/980
(88 %)
6 diff
(99.4 %id)
BU527785 epidermoid carcinoma, cell line, lung .b 2836 to 3711 1 to 880       880/954
(92 %)
12 diff
(98.8 %id)
BE907730 epithelioid carcinoma, Pancreas .b 2856 to 3590 1 to 730       730/732
(99 %)
11 diff
(98.5 %id)
TI_1971557679   .b 2862 to 3845 985 to 10       976/1281
(76 %)
26 diff
(98.0 %id)
CA488457   .b 2880 to 3780 1 to 920       920/988
(93 %)
19 diff
(98.1 %id)
BG168803 hypernephroma, cell line, Kidney .b 2897 to 3653 1 to 745       745/949
(78 %)
23 diff
(97.6 %id)
BQ930238 epidermoid carcinoma, cell line, lung .b 2907 to 3700 1 to 804       801/895
(89 %)
22 diff
(97.6 %id)
BM044352 carcinoma, cell line, Prostate .b 2913 to 3645 1 to 731       731/835
(87 %)
11 diff
(98.7 %id)
BM020114 astrocytoma grade IV, cell line, brain .b 2915 to 3701 1 to 783       783/783
(100 %)
9 diff
(98.9 %id)
BQ928836 carcinoma, cell line, Prostate .b 2915 to 3783 1 to 873       873/928
(94 %)
23 diff
(97.6 %id)
BU541036 epithelioid carcinoma cell line, Pancreas .b 2915 to 3642 1 to 731       731/855
(85 %)
9 diff
(99.0 %id)
TI_59390894   .b 2916 to 3701 97 to 878       782/782
(100 %)
8 diff
(99.0 %id)
BG421419 Kidney, renal cell adenocarcinoma .b 2942 to 3658 1 to 716       714/961
(74 %)
22 diff
(97.8 %id)
DA050255   .b 2961 to 3537 2 to 579   capped   578/579
(99 %)
3 diff
(99.5 %id)
CV572257 cornea, eye .b 2994 to 3630 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BQ935536 carcinoma, cell line, Prostate .b 3056 to 3839 1 to 796       796/1009
(78 %)
17 diff
(98.4 %id)
BQ919472 carcinoma, cell line, Prostate .b 3056 to 3906 1 to 862       862/944
(91 %)
25 diff
(97.4 %id)
CA454511   .b 3057 to 3904 1 to 855       855/893
(95 %)
12 diff
(98.7 %id)
BE563251 adenocarcinoma, Pancreas .b 3106 to 3816 1 to 710       710/968
(73 %)
23 diff
(97.7 %id)
CB131111 Liver .b 3112 to 3680 1 to 569       569/569
(100 %)
0 diff
(100 %id)
AU136460 placenta .b 3140 to 3851 2 to 723   capped   722/722
(100 %)
15 diff
(98.0 %id)
BI915866 brain .b 3166 to 3856 1 to 690       690/690
(100 %)
12 diff
(98.3 %id)
BQ929809 epidermoid carcinoma, cell line, lung .b 3170 to 3816 649 to 1     Submitted on the opposite strand 649/1014
(64 %)
8 diff
(99.3 %id)
TI_57244387   .b 3170 to 3856 35 to 720       686/720
(95 %)
20 diff
(97.3 %id)
CN409340 embryonic stem cells, DMSO-treated H9 cellline .b 3173 to 3878 1 to 707       707/707
(100 %)
6 diff
(99.2 %id)
BG752716 eye, normal pigmented retinal epithelium .b 3183 to 3963 1 to 782       782/782
(100 %)
2 diff
(99.8 %id)
BQ932054 eye, normal pigmented retinal epithelium .b 3185 to 4014 1 to 842       842/882
(95 %)
15 diff
(98.3 %id)
BG425293 Kidney, renal cell adenocarcinoma .b 3203 to 3866 1 to 667       667/667
(100 %)
5 diff
(99.3 %id)
BG831645 epithelioid carcinoma cell line, Pancreas .b 3208 to 4032 1 to 826       826/827
(99 %)
19 diff
(97.8 %id)
BG679668 skin, squamous cell carcinoma .b 3213 to 3870 1 to 654       654/664
(98 %)
15 diff
(97.8 %id)
BG420223 Kidney, renal cell adenocarcinoma .b 3217 to 3995 1 to 768       768/953
(80 %)
28 diff
(97.1 %id)
TI_57167643   .b 3217 to 3934 65 to 794       730/794
(91 %)
22 diff
(97.3 %id)
BI836691 pooled pancreas and spleen .b 3225 to 3934 1 to 721       721/721
(100 %)
16 diff
(97.8 %id)
BG385768 adenocarcinoma cell line, colon .b 3237 to 3898 1 to 662       662/743
(89 %)
14 diff
(98.2 %id)
BM914253 astrocytoma grade IV, cell line, brain .b 3251 to 4184 1 to 951       951/1113
(85 %)
52 diff
(95.4 %id)
BQ893810 ductal carcinoma, cell line, Pancreas .b 3292 to 4152 21 to 895       875/906
(96 %)
35 diff
(96.2 %id)
BQ891699 carcinoma, cell line, Prostate .b 3305 to 4149 1 to 853       853/908
(93 %)
20 diff
(97.8 %id)
BU541309 carcinoma, cell line, Prostate .b 3305 to 4090 1 to 795       795/909
(87 %)
14 diff
(98.5 %id)
BE743008 adenocarcinoma cell line, ovary .b 3348 to 3964 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
BM049350 carcinoma, cell line, Prostate .b 3377 to 4097 2 to 726       725/726
(99 %)
6 diff
(99.2 %id)
BM046997 carcinoma, cell line, Prostate .b 3377 to 4170 2 to 798       797/802
(99 %)
14 diff
(98.3 %id)
CA487170   .b 3381 to 4098 1 to 722       722/848
(85 %)
14 diff
(98.4 %id)
CA488434   .b 3393 to 4312 1 to 921       921/1020
(90 %)
17 diff
(98.4 %id)
BM047126 carcinoma, cell line, Prostate .b 3403 to 4036 1 to 638       638/639
(99 %)
7 diff
(99.0 %id)
BU502768 carcinoma, cell line, Prostate .b 3404 to 4205 13 to 824       812/948
(85 %)
32 diff
(96.7 %id)
BQ918770 carcinoma, cell line, Prostate .b 3405 to 4297 1 to 910       910/959
(94 %)
23 diff
(97.7 %id)
BQ958923 carcinoma, cell line, Prostate .b 3405 to 4297 1 to 903       903/966
(93 %)
15 diff
(98.5 %id)
CN482873 eye .b 3452 to 4100 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
BI006335 kidney_tumor .b 3476 to 3597 137 to 17       121/150
(80 %)
1 diff
(99.4 %id)
AB209658 Spleen .c 1 to 5479 1 to 5479 exact tiling clone,   5479/5479
(100 %)
6 diff
(99.9 %id)
BE171291 head_neck .c 5157 to 5285 1 to 128       128/132
(96 %)
13 diff
(90.2 %id)
AW951340   .c 5165 to 5403 239 to 1     Submitted on the opposite strand 239/276
(86 %)
26 diff
(90.6 %id)
AW149065 Kidney, renal cell tumor .c 5179 to 5479 335 to 34   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 302/308
(98 %)
26 diff
(91.6 %id)
BG236054 blood, lymphocyte .c 5343 to 5488 151 to 6   tiling clone,   146/151
(96 %)
0 diff
(100 %id)
R69418.
matches multiple genes
breast .c 5361 to 5462 102 to 1     also hits gene SOCS3 102/102
(100 %)
0 diff
(100 %id)
AK293323   .d 1 to 1818 1 to 1818   tiling clone,   1818/1818
(100 %)
1 diff
(100.0 %id)
DC300421   .d 1 to 538 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BI711535.
matches multiple genes
insulinoma, Pancreas .d 1740 to 2124 5 to 390   tiling clone, fully sequenced, also hits gene MXI1 386/390
(98 %)
6 diff
(98.5 %id)
BI711827.
matches multiple genes
insulinoma, Pancreas .d 2063 to 2562 517 to 18   tiling clone, fully sequenced, also hits gene MXI1 500/517
(96 %)
0 diff
(100 %id)
AW090243 brain, tumor, 5 pooled (see description) .d 2270 to 2565 296 to 1   tiling clone,   296/296
(100 %)
0 diff
(100 %id)
BQ327973 kidney_tumor .e 1 to 599 23 to 611   tiling clone,   589/611
(96 %)
14 diff
(97.8 %id)
BF907767 uterus_tumor .e 565 to 854 291 to 1   tiling clone, Submitted on the opposite strand 291/291
(100 %)
5 diff
(98.3 %id)
DA627565 Kidney .f 1 to 548 2 to 549 C73X L154P tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DA650627   .g 1 to 545 2 to 546 exact tiling clone, capped   545/545
(100 %)
1 diff
(99.9 %id)
BI008500 kidney_tumor .h-u 1 to 134 1 to 133   tiling clone,   133/133
(100 %)
3 diff
(97.8 %id)
CV395408 lung_tumor .h-u 113 to 508 17 to 411   tiling clone,   395/411
(96 %)
8 diff
(98.1 %id)
AK095140 substantia nigra .h-u 204 to 2698 1 to 2495 exact tiling clone, available from FLJ,   2495/2495
(100 %)
1 diff
(100.0 %id)
DA344014 substantia nigra .h-u 205 to 782 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BG998976 head_neck .h-u 899 to 1417 13 to 529       517/529
(97 %)
6 diff
(98.9 %id)
BI009477 kidney_tumor .h-u 1219 to 1715 1 to 500       500/533
(93 %)
31 diff
(94.2 %id)
BI009478 kidney_tumor .h-u 1227 to 1752 27 to 555       529/564
(93 %)
22 diff
(96.1 %id)
BE812458 amnion_normal .i 1 to 419 11 to 429   tiling clone,   419/429
(97 %)
6 diff
(98.7 %id)
BE812456 amnion_normal .i 7 to 425 429 to 11   tiling clone,   419/442
(94 %)
1 diff
(99.8 %id)
BF353625 head_neck .j 1 to 370 369 to 1 N118T S119A Y120T M121* tiling clone,   371/369
(100 %)
2 diff
(99.5 %id)
BF769694 epid_tumor .k 1 to 351 1 to 351 S7R tiling clone,   351/351
(100 %)
1 diff
(99.8 %id)
DB275862 uterus .l 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
CB140193 Liver .m 1 to 518 1 to 518   tiling clone,   518/518
(100 %)
1 diff
(99.9 %id)
AW085760 esophagus, squamous cell carcinoma .m 157 to 554 435 to 38 exact tiling clone, AAA   399/418
(95 %)
0 diff
(100 %id)
BQ353758 head_neck .n-u 1 to 421 1 to 421   tiling clone,   421/421
(100 %)
5 diff
(98.9 %id)
BF908149 uterus_tumor .n-u 105 to 259 1 to 154       154/154
(100 %)
5 diff
(96.8 %id)
CV373262 lung_tumor .n-u 357 to 794 1 to 438   tiling clone,   438/438
(100 %)
9 diff
(98.0 %id)
BG427294 Kidney .n-u 527 to 1289 1 to 759   tiling clone,   759/759
(100 %)
17 diff
(97.8 %id)
BG401160 Kidney .n-u 539 to 1163 1 to 620   tiling clone,   620/848
(73 %)
23 diff
(97.3 %id)
CB178447 Pancreas, Purified pancreatic islet .n-u 678 to 912 1 to 235   tiling clone,   235/235
(100 %)
4 diff
(98.3 %id)
BF821782 kidney_tumor .n-u 993 to 1500 9 to 512 A5T tiling clone,   504/512
(98 %)
6 diff
(98.9 %id)
BF883234 lung_tumor .n-u 1080 to 1510 451 to 21 S31G tiling clone, Submitted on the opposite strand 431/451
(95 %)
0 diff
(100 %id)
BQ897988 dorsal root ganglia .n-u 1098 to 1910 1 to 814 R16G S31G S32G T35A N40S ... tiling clone,   814/963
(84 %)
29 diff
(97.0 %id)
AA079551 Pancreas .n-u 1226 to 1573 1 to 354       354/354
(100 %)
9 diff
(97.5 %id)
AK090532   .n-u 1370 to 3646 1 to 2278   tiling clone, available from FLJ,   2278/2278
(100 %)
9 diff
(99.7 %id)
DA019048   .n-u 1371 to 1900 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
BE142993 head_neck .n-u 1392 to 1885 495 to 2     Submitted on the opposite strand 494/495
(99 %)
0 diff
(100 %id)
CB121603 Liver .n-u 1774 to 2357 1 to 584   tiling clone,   584/584
(100 %)
0 diff
(100 %id)
BE142525 head_neck .n-u 1843 to 2289 1 to 447       447/453
(98 %)
1 diff
(99.8 %id)
BE142527 head_neck .n-u 1843 to 2282 1 to 440       440/440
(100 %)
0 diff
(100 %id)
AA079552 Pancreas .n-u 2008 to 2429 426 to 1   tiling clone,   426/426
(100 %)
5 diff
(98.9 %id)
DW414536 Liver .n-u 2450 to 2748 17 to 315   tiling clone,   299/315
(94 %)
6 diff
(98.1 %id)
BF948024 nervous_normal .n-u 2969 to 3117 155 to 8       148/155
(95 %)
0 diff
(100 %id)
DB295484   .n-u 3114 to 3646 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
AI537872 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n-u 3275 to 3647 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
DW430882 Liver .n-u 3405 to 3651 21 to 269       249/271
(91 %)
9 diff
(96.7 %id)
DW441998 Liver .n-u 3510 to 3729 17 to 236   tiling clone,   220/236
(93 %)
6 diff
(97.5 %id)
AK092023   .o 1 to 3054 2 to 3052 exact tiling clone, available from FLJ,   3052/3054
(99 %)
2 diff
(100.0 %id)
AX747318   .o 1 to 3054 2 to 3052 exact     3052/3054
(99 %)
2 diff
(100.0 %id)
DA649701   .o 1 to 543 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BI063715 uterus_tumor .o 416 to 653 1 to 237       237/237
(100 %)
3 diff
(98.8 %id)
AL691874   .o 437 to 1086 1 to 650       650/650
(100 %)
4 diff
(99.4 %id)
AK091950 Kidney .o 739 to 3053 1 to 2315 exact available from FLJ,   2315/2315
(100 %)
0 diff
(100 %id)
AX747273   .o 739 to 3053 1 to 2315 exact     2315/2315
(100 %)
0 diff
(100 %id)
DA633808 Kidney .o 740 to 1317 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB163086 thymus .o 781 to 1369 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BE905844 epithelioid carcinoma, Pancreas .o 810 to 1310 1 to 502       502/561
(89 %)
2 diff
(99.7 %id)
DB321656   .o 2501 to 3054 556 to 3       554/556
(99 %)
0 diff
(100 %id)
DB320952 Kidney .o 2529 to 3053 528 to 1       528/528
(100 %)
3 diff
(99.5 %id)
CA453892   .p 1 to 825 1 to 827 R137P W138L L139A V140G P142A ... tiling clone,   827/870
(95 %)
6 diff
(99.4 %id)
CA454667   .p 43 to 915 1 to 878 W138L L139A V140G Q143P tiling clone,   878/891
(98 %)
9 diff
(99.0 %id)
BG164865 hypernephroma, cell line, Kidney .p 56 to 575 1 to 520       520/520
(100 %)
0 diff
(100 %id)
CA488742   .p 67 to 926 1 to 876 W138L L139A V140G Q143P tiling clone,   876/904
(96 %)
21 diff
(97.7 %id)
CA487327   .p 71 to 920 1 to 858 W138L L139A V140G Q143P tiling clone,   858/858
(100 %)
17 diff
(98.1 %id)
CA488187   .p 78 to 902 1 to 837 R137X W138L L139A V140G Q143P     837/848
(98 %)
11 diff
(98.8 %id)
CA487756   .p 79 to 926 1 to 864 exact tiling clone,   864/893
(96 %)
19 diff
(97.9 %id)
BM838209 Ascites, stomach .p 79 to 646 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
BQ676723 melanotic melanoma, cell line, skin .p 87 to 361 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AW848555 colon .q-u 1 to 299 299 to 1 N28D W62* tiling clone,   299/299
(100 %)
3 diff
(99.0 %id)
BI007484 kidney_tumor .r 1 to 227 227 to 1 S15F D23A R24E V25S R26G ... tiling clone,   227/227
(100 %)
3 diff
(98.7 %id)
AK303384 thymus Gene ITGA3, variant not shown         Suspected internal deletion, this clone was ignored    
BG979929 colon_normal Gene ITGA3, variant not shown         Suspected internal deletion, this clone was ignored    
BP223758 colon mucosa Gene ITGA3, variant not shown         Suspected internal deletion, this clone was ignored    
AA872760 2 pooled tumors (clear cell type), Kidney Gene ITGA3, variant not shown         Suspected internal deletion, this clone was ignored    
AI816735 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) Gene ITGA3, variant not shown         Suspected internal deletion, this clone was ignored    
BE562806 endometrium, adenocarcinoma cell line, uterus Gene ITGA3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BC015344 Kidney, hypernephroma Gene ITGA3, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BQ773260 Chondrosarcoma Cell line Gene ITGA3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n-u, .o, .p, .q-u, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI